SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Takeda 12-Month Price Target Raised to $21.12

The headline reports a raised 12-month price target of $21.12 for Takeda Pharmaceutical Company Limited.

4502

Related stories